The effectiveness of GLP-1 analogues compared to DPP-4 inhibitors for beta cell function and diabetes related complications among adults with type 2 diabetes: a systematic review protocol

Simple item page
dc.contributor.authorBellman, S.
dc.contributor.authorAromataris, E.
dc.date.issued2014
dc.description.abstractReview question/objective: What is the effectiveness of GLP-1 analogues compared to DPP-4 inhibitors for beta cell function and diabetes related complications among adults with type 2 diabetes?
dc.description.statementofresponsibilitySusan Marie Bellman, Edoardo Aromataris
dc.identifier.citationThe JBI Database of Systematic Reviews and Implementation Reports, 2014; 12(10):3-13
dc.identifier.doi10.11124/jbisrir-2014-1858
dc.identifier.issn2202-4433
dc.identifier.issn2202-4433
dc.identifier.orcidBellman, S. [0000-0001-7418-4226]
dc.identifier.urihttp://hdl.handle.net/2440/94153
dc.language.isoen
dc.publisherJoanna Briggs Institute and The University of Adelaide
dc.rightsCopyright status unknown. Open access
dc.source.urihttp://dx.doi.org/10.11124/jbisrir-2014-1858
dc.subjecttype 2 diabetes; beta-cell function; beta-cell preservation; dipeptidyl peptidase-4 inhibitors; DPP-4 inhibitors; glucagon-like peptide analogues; GLP-1 analogues
dc.titleThe effectiveness of GLP-1 analogues compared to DPP-4 inhibitors for beta cell function and diabetes related complications among adults with type 2 diabetes: a systematic review protocol
dc.typeJournal article
pubs.publication-statusPublished

Files

Collections

Translational Health Science publications